The Epilepsy Foundation supports funding for better treatments for epilepsy and a cure. We urge Congress to continue to invest in research initiatives at the National Institutes of Health (NIH) and to specifically support funding for initiatives at National Institute of Neurological Disorders and Stroke (NINDS).
Advocacy News - NIH Funding
On April 12, 2017, Epilepsy Foundation Director of the Epilepsy Innovation Institute (Ei2) Sonya B. Dumanis, PhD. authored a blog post on epilepsy research at NIH. As the new Administration begins to discuss the federal budget and potential cuts to funding at NIH and other programs, we must raise awareness with all stakeholders about the critical role federal investments in biomedical research play for epilepsy research priorities and the overall research enterprise. The research supported by NIH is an essential component that can be complemented, but not matched or replaced, by the nonprofit community's investments in research.
Read the blog post here.
On February 7, 2017, the Epilepsy Foundation joined 260 member organizations of the Ad Hoc Group for Medical Research in a letter urging President Trump and Congressional leaders to approve a Senate Appropriations Committee-approved $34.1 billion in Fiscal Year (FY) 2017 funding for the National Institutes of Health (NIH). The letter also emphasized the importance of ensuring that funding for NIH remains a top priority in FY 2018 and beyond. The Epilepsy Foundation supports funding increases for epilepsy research at the National Institutes of Health that bring us closer to better treatments for epilepsy and a cure. Read our coalition letter below.
Ad Hoc Group NIH Support Letter (Feb 7 2017)